A detailed history of W.G. Shaheen & Associates Dba Whitney & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, W.G. Shaheen & Associates Dba Whitney & CO holds 110,277 shares of MRK stock, worth $10.8 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
110,277
Previous 110,247 0.03%
Holding current value
$10.8 Million
Previous $13.6 Million 8.24%
% of portfolio
1.37%
Previous 1.59%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$111.15 - $128.97 $3,334 - $3,869
30 Added 0.03%
110,277 $12.5 Million
Q2 2024

Jul 30, 2024

SELL
$123.8 - $132.96 $234,724 - $252,092
-1,896 Reduced 1.69%
110,247 $13.6 Million
Q1 2024

May 08, 2024

SELL
$113.24 - $131.95 $175,408 - $204,390
-1,549 Reduced 1.36%
112,143 $14.8 Million
Q4 2023

Feb 08, 2024

SELL
$100.18 - $109.02 $135,343 - $147,286
-1,351 Reduced 1.17%
113,692 $12.4 Million
Q3 2023

Nov 08, 2023

SELL
$102.95 - $114.33 $157,925 - $175,382
-1,534 Reduced 1.32%
115,043 $11.8 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $78,090 - $85,115
-719 Reduced 0.61%
116,577 $13.5 Million
Q1 2023

May 03, 2023

SELL
$102.94 - $114.86 $1.09 Million - $1.22 Million
-10,607 Reduced 8.29%
117,296 $12.5 Million
Q4 2022

Feb 03, 2023

SELL
$87.44 - $112.11 $55,699 - $71,414
-637 Reduced 0.5%
127,903 $14.2 Million
Q3 2022

Nov 09, 2022

BUY
$84.53 - $94.96 $25,866 - $29,057
306 Added 0.24%
128,540 $11.1 Million
Q2 2022

Aug 05, 2022

SELL
$83.49 - $94.64 $1,753 - $1,987
-21 Reduced 0.02%
128,234 $11.7 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $25,875 - $29,004
352 Added 0.28%
128,255 $10.5 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $56,233 - $70,440
778 Added 0.61%
127,903 $9.8 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $118,845 - $130,700
1,658 Added 1.32%
127,125 $9.55 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $149,127 - $164,950
2,121 Added 1.72%
125,467 $9.76 Million
Q1 2021

May 11, 2021

BUY
$68.86 - $81.11 $151,905 - $178,928
2,206 Added 1.82%
123,346 $9.51 Million
Q4 2020

Feb 10, 2021

BUY
$71.77 - $79.65 $74,784 - $82,995
1,042 Added 0.87%
121,140 $9.72 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $54,299 - $61,548
742 Added 0.62%
120,098 $9.96 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $5,070 - $5,769
72 Added 0.06%
119,356 $9.23 Million
Q1 2020

May 05, 2020

BUY
$63.36 - $87.82 $1.53 Million - $2.12 Million
24,100 Added 25.32%
119,284 $9.18 Million
Q4 2019

Feb 06, 2020

SELL
$77.58 - $87.54 $138,868 - $156,696
-1,790 Reduced 1.85%
95,184 $8.66 Million
Q3 2019

Nov 07, 2019

BUY
$76.08 - $82.93 $223,218 - $243,316
2,934 Added 3.12%
96,974 $8.14 Million
Q2 2019

Aug 06, 2019

BUY
$69.84 - $81.59 $14,317 - $16,725
205 Added 0.22%
94,040 $7.89 Million
Q1 2019

May 06, 2019

BUY
$69.58 - $79.36 $143,682 - $163,878
2,065 Added 2.25%
93,835 $7.39 Million
Q4 2018

Feb 07, 2019

BUY
$65.24 - $75.71 $139,287 - $161,640
2,135 Added 2.38%
91,770 $7.05 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $220,664 - $259,488
3,825 Added 4.46%
89,635 $6.77 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $66,180 - $77,755
1,302 Added 1.54%
85,810 $5.21 Million
Q1 2018

May 11, 2018

BUY
$50.96 - $59.23 $51,571 - $59,940
1,012 Added 1.21%
84,508 $4.6 Million
Q4 2017

Feb 12, 2018

SELL
$51.62 - $61.64 $5,110 - $6,102
-99 Reduced 0.12%
83,496 $4.7 Million
Q3 2017

Nov 03, 2017

BUY
$58.67 - $63.13 $2,933 - $3,156
50 Added 0.06%
83,595 $5.36 Million
Q2 2017

Aug 11, 2017

BUY
N/A
83,545
83,545 $5.35 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track W.G. Shaheen & Associates Dba Whitney & CO Portfolio

Follow W.G. Shaheen & Associates Dba Whitney & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of W.G. Shaheen & Associates Dba Whitney & CO, based on Form 13F filings with the SEC.

News

Stay updated on W.G. Shaheen & Associates Dba Whitney & CO with notifications on news.